Cellular Biomedicine Group
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $120M
Investors
- 5
About Cellular Biomedicine Group
Based in the US, Cellular Biomedicine Group, Inc.Cellular Biomedicine Group, Inc. operates in the biopharmaceutical sector, developing therapies for cancer treatment.Cellular Biomedicine Group, Inc. specializes in developing T cell-based therapeutics, including Chimeric Antigen Receptor T cell (CAR-T) therapies and Tumor Infiltrating Lymphocytes (TIL) aimed at treating various cancers and immunological conditions.In the most recent reporting year, 2019, Cellular Biomedicine Group, Inc.00 mn, Cellular Biomedicine Group, Inc. aims to accelerate the clinical development of its immune-oncology platform. This includes advancements in therapies involving C-CAR039 and C-CAR088, along with armored CAR-T and TIL therapies targeting solid tumors.
Who invested in Cellular Biomedicine Group
5 investors across 1 round
See all investors in Cellular Biomedicine Group
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 29, 2021
Amount
$120M
Investors
Questions about Cellular Biomedicine Group
Who invested in Cellular Biomedicine Group?
Cellular Biomedicine Group has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellular Biomedicine Group raised?
Cellular Biomedicine Group has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cellular Biomedicine Group last raise money?
Cellular Biomedicine Group's most recent round on record is a Series A, in Sep 2021.
What does Cellular Biomedicine Group do?
Based in the US, Cellular Biomedicine Group, Inc.
Where is Cellular Biomedicine Group headquartered?
Cellular Biomedicine Group is headquartered in Rockville, US.
Which VCs invest in companies like Cellular Biomedicine Group?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cellular Biomedicine Group's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cellular Biomedicine Group? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.